Indirect Radioiodination of DARPin G3 Using N-succinimidyl-Para-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging.

Published on Jun 21, 2019in International Journal of Molecular Sciences4.556
· DOI :10.3390/IJMS20123047
Anzhelika Vorobyeva11
Estimated H-index: 11
(Uppsala University),
Alexey A. Schulga14
Estimated H-index: 14
(RAS: Russian Academy of Sciences)
+ 4 AuthorsVladimir Tolmachev61
Estimated H-index: 61
(Uppsala University)
Sources
Abstract
Radionuclide molecular imaging of human epidermal growth factor receptor 2 (HER2) in breast and gastroesophageal cancer might be used to stratify patients for HER2-targeted therapy as well as monitor treatment response and disease progression. Designed ankyrin repeat proteins (DARPins) are small engineered scaffold proteins with favorable properties for molecular imaging. Herein we compared two methods for labeling the anti-HER2 DARPin (HE)3-G3, direct and indirect radioiodination. We hypothesized that the use of N-succinimidyl-para-iodobenzoate (SPIB) for radioiodination would facilitate the clearance of radiometabolites and improve the contrast of imaging. Both radiolabeled (HE)3-G3 variants preserved their binding specificity and high affinity to HER2-expressing cells. The specificity of tumor targeting in vivo was also demonstrated. A biodistribution comparison of [125I]I-(HE)3-G3 and [125I]I-PIB-(HE)3-G3, in mice bearing HER2 expressing SKOV3 xenografts, showed rapid clearance of [125I]I-PIB-(HE)3-G3 from normal organs and tissues and low accumulation of activity in organs with NaI-symporter expression. Both radiolabeled (HE)3-G3 variants had equal tumor uptake. Consequently, the indirect label provided higher tumor-to-blood and tumor-to-organ ratios compared with the direct label. Comparative Single Photon Emission Computed Tomography (SPECT)/CT imaging of HER2 expression in SKOV3 xenografts, using both radiolabeled DARPins, demonstrated the superior imaging contrast of the indirect label. Indirect radioiodination of (HE)3-G3 using SPIB could be further applied for SPECT and PET imaging with iodine-123 and iodine-124.
Download
📖 Papers frequently viewed together
16 Citations
55 Citations
11 Citations
References45
Newest
#1Anzhelika Vorobyeva (Uppsala University)H-Index: 11
#2Alexey A. Schulga (RAS: Russian Academy of Sciences)H-Index: 14
Last. Sergey M. Deyev (Tomsk Polytechnic University)H-Index: 29
view all 12 authors...
Radionuclide molecular imaging of HER2 expression in disseminated cancer enables stratification of patients for HER2-targeted therapies. DARPin G3, a small (14 kDa) engineered scaffold protein, is a promising probe for imaging of HER2. We hypothesized that position (C- or N-terminus) and composition (hexahistidine or (HE)3) of histidine-containing tags would influence the biodistribution of [99mTc]Tc(CO)3-labeled DARPin G3. To test the hypothesis, G3 variants containing tags at N-terminus (H6-G3...
14 CitationsSource
#1Anzhelika Vorobyeva (Uppsala University)H-Index: 11
#2Alexey Sсhulga (RAS: Russian Academy of Sciences)H-Index: 1
Last. Vladimir Tolmachev (Uppsala University)H-Index: 61
view all 11 authors...
Evaluation of human epidermal growth factor receptor 2 (HER2) expression levels in breast and gastroesophageal cancer is used for the stratification of patients for HER2-targeting therapies. The us ...
11 CitationsSource
#1Sergey M. Deyev (National Research Nuclear University MEPhI)H-Index: 29
#2Anzhelika VorobyevaH-Index: 11
Last. Vladimir TolmachevH-Index: 61
view all 13 authors...
Designed ankyrin repeat proteins (DARPins) are small engineered scaffold proteins that can be selected for binding to desirable molecular targets. High affinity and small size of DARPins render the ...
16 CitationsSource
#1Javad Garousi (Uppsala University)H-Index: 13
#2Sarah Lindbo (KTH: Royal Institute of Technology)H-Index: 8
Last. Sophia Hober (KTH: Royal Institute of Technology)H-Index: 41
view all 11 authors...
Abstract ADAPTs are small engineered non-immunoglobulin scaffold proteins, which have demonstrated very promising features as vectors for radionuclide tumour targeting. Radionuclide imaging of human epidermal growth factor 2 (HER2) expression in vivo might be used for stratification of patients for HER2-targeting therapies. ADAPT6, which specifically binds to HER2, has earlier been shown to have very promising features for in vivo targeting of HER2 expressing tumours. In this study we tested the...
11 CitationsSource
#1Kelly E. Henry (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 4
#2Gary A. Ulaner (Cornell University)H-Index: 28
Last. Jason S. LewisH-Index: 87
view all 3 authors...
Breast cancer is the most common cancer in women worldwide, with approximately 12% of women in the United States developing invasive breast cancer in her lifetime.1 Although breast cancer has come a long way in regards to treatment options and overall survival, there are still challenges that occur mostly from intratumoral heterogeneity2 and metastatic disease.3 While significant research has emerged to identify biological processes leading to breast cancer,4 selecting patients that would benefi...
11 CitationsSource
#1Anzhelika Vorobyeva (Uppsala University)H-Index: 11
#2Olga Bragina (RAS: Russian Academy of Sciences)H-Index: 4
Last. Sergey M. Deyev (Tomsk Polytechnic University)H-Index: 29
view all 10 authors...
High expression of human epidermal growth factor receptor 2 (HER2) in breast and gastroesophageal carcinomas is a predictive biomarker for treatment using HER2-targeted therapeutics (antibodies trastuzumab and pertuzumab, antibody-drug conjugate trastuzumab DM1, and tyrosine kinase inhibitor lapatinib). Radionuclide molecular imaging of HER2 expression might permit stratification of patients for HER2-targeting therapies. In this study, we evaluated a new HER2-imaging probe based on the designed ...
22 CitationsSource
#1Ahmet KrasniqiH-Index: 8
Last. Vladimir Tolmachev (Uppsala University)H-Index: 61
view all 8 authors...
Imaging of expression of therapeutic targets may enable patients' stratification for targeted treatments. The use of small radiolabeled probes based on the heavy-chain variable region of heavy-chai ...
55 CitationsSource
#1Sarah Lindbo (KTH: Royal Institute of Technology)H-Index: 8
#2Javad Garousi (Uppsala University)H-Index: 13
Last. Vladimir Tolmachev (Uppsala University)H-Index: 61
view all 8 authors...
Visualization of cancer-associated alterations of molecular phenotype using radionuclide imaging is a noninvasive approach to stratifying patients for targeted therapies. The engineered albumin-bin ...
24 CitationsSource
Nonimmunoglobulin scaffolds have been developed to overcome the limitations of monoclonal antibodies with regard to stability and size. Of these scaffolds, the class of designed ankyrin repeat proteins (DARPins) has advanced the most in biochemical and biomedical applications. This review focuses on the recent progress in DARPin technology, highlighting the scaffold's potential and possibilities.
10 CitationsSource
#1Kelly E. Henry (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 4
#2Gary A. Ulaner (Cornell University)H-Index: 28
Last. Jason S. Lewis (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 87
view all 3 authors...
: Increased human epidermal growth factor receptor 2 (HER2) expression is a hallmark of aggressive breast cancer. Imaging modalities have the potential to diagnose HER2-positive breast cancer and detect distant metastases. The heterogeneity of HER2 expression between primary and metastatic disease sites limits the value of tumor biopsies. Molecular imaging is a noninvasive tool to assess HER2-positive primary lesions and metastases. Radiolabeled antibodies, antibody fragments, and affibody molec...
23 CitationsSource
Cited By10
Newest
#1Tianqi Xu (Uppsala University)H-Index: 2
#2Anzhelika Vorobyeva (Uppsala University)H-Index: 11
Last. Vladimir Tolmachev (Uppsala University)H-Index: 61
view all 11 authors...
Efficient treatment of disseminated ovarian cancer (OC) is challenging due to its heterogeneity and chemoresistance. Overexpression of human epidermal growth factor receptor 2 (HER2) and epithelial cell adhesion molecule (EpCAM) in approx. 30% and 70% of ovarian cancers, respectively, allows for co-targeted treatment. The clinical efficacy of the monoclonal antibody trastuzumab in patients with HER2-positive breast, gastric and gastroesophageal cancers makes it readily available as the HER2-targ...
Source
#1Vladimir Tolmachev (Tomsk Polytechnic University)H-Index: 61
#2Anna Orlova (Tomsk Polytechnic University)H-Index: 53
Last. Jens Nørkær Sørensen (Uppsala University)H-Index: 66
view all 3 authors...
Abstract Targeting of human epidermal growth factor type 2 (HER2) using monoclonal antibodies, antibody-drug conjugates and tyrosine kinase inhibitors extends survival of patients with HER2-expressing metastatic breast cancer. High expression of HER2 is a predictive biomarker for such specific treatment. Accurate determination of HER2 expression level is necessary for stratification of patients to targeted therapy. Non-invasive in vivo radionuclide molecular imaging of HER2 has a potential of re...
1 CitationsSource
#1Sara S. RinneH-Index: 8
#2Anna Orlova (Tomsk Polytechnic University)H-Index: 53
Last. Vladimir TolmachevH-Index: 61
view all 3 authors...
The human epidermal growth factor receptor family (EGFR-family, other designations: HER family, RTK Class I) is strongly linked to oncogenic transformation. Its members are frequently overexpressed in cancer and have become attractive targets for cancer therapy. To ensure effective patient care, potential responders to HER-targeted therapy need to be identified. Radionuclide molecular imaging can be a key asset for the detection of overexpression of EGFR-family members. It meets the need for rep...
Source
#1Javad Garousi (Uppsala University)H-Index: 13
#2Emma von Witting (KTH: Royal Institute of Technology)H-Index: 4
Last. Sophia Hober (KTH: Royal Institute of Technology)H-Index: 41
view all 11 authors...
Abstract Molecular recognition in targeted therapeutics is typically based on immunoglobulins. Development of engineered scaffold proteins (ESPs) has provided additional opportunities for the development of targeted therapies. ESPs offer inexpensive production in prokaryotic hosts, high stability and convenient approaches to modify their biodistribution. In this study, we demonstrated successful modification of the biodistribution of an ESP known as ADAPT (Albumin-binding domain Derived Affinity...
1 CitationsSource
#1Anzhelika Vorobyeva (Uppsala University)H-Index: 11
#2Ekaterina Bezverkhniaia (Tomsk Polytechnic University)H-Index: 1
Last. Vladimir Tolmachev (Uppsala University)H-Index: 61
view all 10 authors...
Efficient treatment of disseminated triple-negative breast cancer (TNBC) remains an unmet clinical need. The epithelial cell adhesion molecule (EpCAM) is often overexpressed on the surface of TNBC cells, which makes EpCAM a potential therapeutic target. Radionuclide molecular imaging of EpCAM expression might permit selection of patients for EpCAM-targeting therapies. In this study, we evaluated a scaffold protein, designed ankyrin repeat protein (DARPin) Ec1, for imaging of EpCAM in TNBC. DARPi...
4 CitationsSource
#1Anzhelika Vorobyeva (Uppsala University)H-Index: 11
#2E. A. Konovalova (RAS: Russian Academy of Sciences)H-Index: 4
Last. Sergey Deyev (Tomsk Polytechnic University)H-Index: 2
view all 10 authors...
Epithelial cell adhesion molecule (EpCAM) is overexpressed in 55%–75% of ovarian carcinomas (OC). EpCAM might be used as a target for a treatment of disseminated OC. Designed ankyrin repeats protein (DARPin) Ec1 is a small (18 kDa) protein, which binds to EpCAM with subnanomolar affinity. We tested a hypothesis that Ec1 labeled with a non-residualizing label might serve as a companion imaging diagnostic for stratification of patients for EpCAM-targeting therapy. Ec1 was labeled with 125I using N...
5 CitationsSource
#1Sara S. Rinne (Uppsala University)H-Index: 8
#2Tianqi Xu (Uppsala University)H-Index: 2
Last. Anzhelika Vorobyeva (Uppsala University)H-Index: 11
view all 8 authors...
Human epidermal growth factor receptor type 3 (HER3) is an emerging therapeutic target in several malignancies. To select potential responders to HER3-targeted therapy, radionuclide molecular imaging of HER3 expression using affibody molecules could be performed. Due to physiological expression of HER3 in normal organs, high imaging contrast remains challenging. Due to slow internalization of affibody molecules by cancer cells, we hypothesized that labeling (HE)3-ZHER3:08698-DOTAGA affibody mole...
3 CitationsSource
#1Sergey M. Deyev (Tomsk Polytechnic University)H-Index: 29
#2Anzhelika Vorobyeva (Tomsk Polytechnic University)H-Index: 11
Last. Vladimir Tolmachev (Tomsk Polytechnic University)H-Index: 61
view all 11 authors...
Abstract Radionuclide-based imaging of molecular therapeutic targets might facilitate stratifying patients for specific biotherapeutics. New type of imaging probes, based on designed ankyrin repeat proteins (DARPins), have demonstrated excellent contrast of imaging of human epidermal growth factor type 2 (HER2) expression in preclinical models. We hypothesized that labeling approaches, which result in lipophilic radiometabolites (non-residualizing labels), would provide the best imaging contrast...
9 CitationsSource
#1Mohamed Altai (Uppsala University)H-Index: 19
#2Javad Garousi (Uppsala University)H-Index: 13
Last. Anzhelika Vorobyeva (Tomsk Polytechnic University)H-Index: 11
view all 6 authors...
BACKGROUND: Designed ankyrin repeat proteins (DARPins) are small engineered scaffold proteins (14-18 kDa) that demonstrated promising tumor-targeting properties in preclinical studies. However, high renal accumulation of activity for DARPins labeled with residualizing labels is a limitation for targeted radionuclide therapy. A better understanding of the mechanisms behind the kidney uptake of DARPins could aid the development of strategies to reduce it. In this study, we have investigated whethe...
7 CitationsSource
#1Sarah Lindbo (KTH: Royal Institute of Technology)H-Index: 8
#2Javad Garousi (Uppsala University)H-Index: 13
Last. Vladimir Tolmachev (Uppsala University)H-Index: 61
view all 8 authors...
Visualization of cancer-associated alterations of molecular phenotype using radionuclide imaging is a noninvasive approach to stratifying patients for targeted therapies. The engineered albumin-bin ...
24 CitationsSource